• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌患者术前血清癌胚抗原和糖类抗原19-9——一家三级医院对1075例患者的单中心研究

Preoperative serum CEA and CA19-9 in gastric cancer--a single tertiary hospital study of 1,075 cases.

作者信息

Zhou Yang-Chun, Zhao Hai-Jian, Shen Li-Zong

机构信息

Division of Gastrointestinal Surgery, Department of General Surgery, First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China E-mail :

出版信息

Asian Pac J Cancer Prev. 2015;16(7):2685-91. doi: 10.7314/apjcp.2015.16.7.2685.

DOI:10.7314/apjcp.2015.16.7.2685
PMID:25854347
Abstract

To evaluate the clinical impact of preoperative serum CEA and CA19-9 on resectable gastric cancer (GC), a total of 1,075 consecutive cases with gastric adenocarcinoma were obtained retrospectively from January 2012 and December 2013 in a single tertiary hospital, and the relationships between serum CEA, CA19-9 and clinicopathologic features were investigated. Positive preoperative serum rates of CEA and CA19-9 were 22.4% and 12.3% respectively, levels significantly correlating with each other and depth of invasion, lymph node involvement, pTNM and stage. The CEA level also presented a remarkable association with lymphovascular invasion. Both CEA and CA19-9 positivity significantly and positively correlated with depth of invasion, nodal involvement, pTNM stage, lymphovascular invasion, tumor size and tumor location. Stratified analyses according to gender or tumor location showed preoperative CEA or CA19-9 had different associations with clinicopathologic features in different gender subgroups or location subgroups. Preoperative serum CA19-9 positivity may be more meaningful for tumor size rather than CEA. In conclusion, preoperative serum CEA and CA19-9 correlate with disease progression of GC, and may have applications in aiding more accurate estimation of tumor stage, decision of treatment choice and prognosis evaluation.

摘要

为评估术前血清癌胚抗原(CEA)和糖类抗原19-9(CA19-9)对可切除胃癌(GC)的临床影响,我们于2012年1月至2013年12月在一家三级医院回顾性收集了1075例连续的胃腺癌病例,并研究了血清CEA、CA19-9与临床病理特征之间的关系。术前血清CEA和CA19-9的阳性率分别为22.4%和12.3%,其水平彼此显著相关,且与浸润深度、淋巴结受累情况、pTNM分期及临床分期相关。CEA水平还与淋巴管侵犯显著相关。CEA和CA19-9阳性均与浸润深度、淋巴结受累情况、pTNM分期、淋巴管侵犯、肿瘤大小及肿瘤位置显著正相关。根据性别或肿瘤位置进行分层分析显示,术前CEA或CA19-9在不同性别亚组或位置亚组中与临床病理特征的关联不同。术前血清CA19-9阳性对肿瘤大小可能比CEA更有意义。总之,术前血清CEA和CA19-9与胃癌的疾病进展相关,可能有助于更准确地评估肿瘤分期、决定治疗选择及评估预后。

相似文献

1
Preoperative serum CEA and CA19-9 in gastric cancer--a single tertiary hospital study of 1,075 cases.胃癌患者术前血清癌胚抗原和糖类抗原19-9——一家三级医院对1075例患者的单中心研究
Asian Pac J Cancer Prev. 2015;16(7):2685-91. doi: 10.7314/apjcp.2015.16.7.2685.
2
The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer.胃癌患者术前和术后血清 CEA 和 CA19-9 的变化及其临床意义。
Clin Lab. 2020 Apr 1;66(4). doi: 10.7754/Clin.Lab.2019.190732.
3
Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.胃癌患者肿瘤标志物的临床评估与预后评价。
Int J Biol Markers. 2013 Jun 28;28(2):192-200. doi: 10.5301/jbm.5000023.
4
The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.癌胚抗原、CA19.9和CA72.4的血清及胃液水平在胃癌患者中的作用
J Cancer Res Clin Oncol. 1998;124(8):450-5. doi: 10.1007/s004320050198.
5
Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?术前肿瘤标志物独立预测 III 期胃癌患者的生存:我们是否应将肿瘤标志物纳入 AJCC 分期?
Ann Surg Oncol. 2018 Sep;25(9):2703-2712. doi: 10.1245/s10434-018-6634-z. Epub 2018 Jul 3.
6
Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.术前血清中五种肿瘤标志物(癌胚抗原、CA19-9、甲胎蛋白、CA72-4和CA125)水平在胃癌中的预后价值
Hepatogastroenterology. 2014 May;61(131):863-9.
7
Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.术前癌胚抗原和糖类抗原19-9水平在胃癌中的临床意义
J Clin Gastroenterol. 2001 Jan;32(1):41-4. doi: 10.1097/00004836-200101000-00010.
8
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.胃癌患者中CA72-4与CEA和CA19-9相比的临床意义及预后价值
Dis Markers. 2000;16(3-4):105-10. doi: 10.1155/2000/595492.
9
The use of tumor markers as predictors of prognosis in gastric cancer.肿瘤标志物在胃癌预后预测中的应用。
Hepatogastroenterology. 2004 Sep-Oct;51(59):1544-7.
10
Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma.术前血清CA125、CA19-9和CEA在胃癌中的预后意义。
Oncotarget. 2016 Jun 7;7(23):35423-36. doi: 10.18632/oncotarget.8770.

引用本文的文献

1
Correlation and predictive modeling of serum exosomal miRNAs and serological biomarkers for lymph node metastasis in gastric cancer.血清外泌体微小RNA与血清学生物标志物在胃癌淋巴结转移中的相关性及预测模型
Am J Cancer Res. 2025 Jun 15;15(6):2579-2594. doi: 10.62347/AOJE4206. eCollection 2025.
2
Nutritional and Biochemical Outcomes After Total Versus Subtotal Gastrectomy: Insights into Early Postoperative Prognosis.全胃切除术与次全胃切除术后的营养和生化结果:对术后早期预后的见解
Nutrients. 2025 Jun 27;17(13):2146. doi: 10.3390/nu17132146.
3
Diagnostic value of systemic immune-inflammation index and prognostic nutritional index combined with CEA in gastric cancer with lymph node metastasis.
全身免疫炎症指数和预后营养指数联合癌胚抗原在胃癌伴淋巴结转移中的诊断价值
Front Endocrinol (Lausanne). 2025 Apr 14;16:1522349. doi: 10.3389/fendo.2025.1522349. eCollection 2025.
4
Serum tumor markers (carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4, carbohydrate antigen 24-2, ferritin) and gastric cancer prognosis correlation.血清肿瘤标志物(癌胚抗原、糖类抗原19-9、糖类抗原72-4、糖类抗原24-2、铁蛋白)与胃癌预后的相关性。
World J Gastrointest Surg. 2024 Sep 27;16(9):2808-2814. doi: 10.4240/wjgs.v16.i9.2808.
5
Development and Validation of Tumor Marker Indices in Advanced Gastric Cancer Patients.晚期胃癌患者肿瘤标志物指标的建立与验证。
Cancer Control. 2023 Jan-Dec;30:10732748231202466. doi: 10.1177/10732748231202466.
6
Clinicopathological characteristics and treatment outcome of resectable gastric cancer patients with small para-aortic lymph node.可切除的伴有小主动脉旁淋巴结的胃癌患者的临床病理特征及治疗结果
Front Oncol. 2023 Feb 27;13:1131725. doi: 10.3389/fonc.2023.1131725. eCollection 2023.
7
Development and external validation of a radiomics model for assessment of HER2 positivity in men and women presenting with gastric cancer.用于评估胃癌患者HER2阳性状态的放射组学模型的开发与外部验证
Insights Imaging. 2023 Feb 1;14(1):20. doi: 10.1186/s13244-022-01361-x.
8
Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy.新型药物递送系统作为胃癌治疗的新兴平台
Pharmaceutics. 2022 Jul 29;14(8):1576. doi: 10.3390/pharmaceutics14081576.
9
Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study.多种肿瘤标志物与新诊断胃癌患者的相关性:一项回顾性研究。
PeerJ. 2022 May 19;10:e13488. doi: 10.7717/peerj.13488. eCollection 2022.
10
Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study.预测肝门部胆管癌根治性切除术后无复发生存的预后模型的开发与验证:一项多中心研究
Front Oncol. 2022 Apr 21;12:849053. doi: 10.3389/fonc.2022.849053. eCollection 2022.